The majority of patients (n = 78; 85.7%) had a
prior diagnosis of cancer, with the most common types being
hematologic malignancies (n = 21; 23.1%), breast cancer (n =
13; 14.3%), and lung cancer (n = 8; 8.8%). At
the time of examination, 25 patients (27.5%) were receiving oncologic
treatment, including chemotherapy, immunotherapy, or radiotherapy. Additional comorbidities were identified
in 17 patients (18.7%), with cardiopathy and pneumopathy being the
most frequent, each occurring in 6 cases (6.6%).